| 000 | 01627 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513090246.0 | ||
| 264 | 0 | _c19960606 | |
| 008 | 199606s 0 0 eng d | ||
| 022 | _a0002-9165 | ||
| 024 | 7 |
_a10.1093/ajcn/63.5.722 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWinklhofer-Roob, B M | |
| 245 | 0 | 0 |
_aLong-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations. _h[electronic resource] |
| 260 |
_bThe American journal of clinical nutrition _cMay 1996 |
||
| 300 |
_a722-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntioxidants _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aCystic Fibrosis _xblood |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLiver Diseases _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTocopherols |
| 650 | 0 | 4 |
_aVitamin E _xadministration & dosage |
| 650 | 0 | 4 |
_aVitamin E Deficiency _xetiology |
| 650 | 0 | 4 |
_aalpha-Tocopherol _xanalogs & derivatives |
| 700 | 1 | _avan't Hof, M A | |
| 700 | 1 | _aShmerling, D H | |
| 773 | 0 |
_tThe American journal of clinical nutrition _gvol. 63 _gno. 5 _gp. 722-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/ajcn/63.5.722 _zAvailable from publisher's website |
| 999 |
_c8614400 _d8614400 |
||